RESULTS FOR : 'immunogenicity'
Showing 1 to 3 of 3 results |    
Keyword Search
Show#
Show#
Results Category/Section
Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Gyros Protein Technologies AB, has announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.

Current and emerging trends in immunogenicity research. Spring 12

In November 2011 Drug Discovery World hosted a collegial style roundtable discussion on the present and emerging developments in this fundamental area of drug discovery and development. The participants are drawn from the biopharmaceutical, biotechnology and vendor community. Although somewhat sketchy in places this is a transcript of what was discussed in what was a lively and interesting debate.

Immunogenicity of therapeutic proteins. Summer 06

Therapeutic proteins enter the market in increasing numbers, and current observations confirm that most of these biopharmaceuticals are to a variable extent immunogenic.